Lari Eisa, Burhamah Waleed, Lari Ali, Alsaeed Talal, Al-Yaqout Khalid, Al-Sabah Salman
General Surgery Department, Jaber Al-Ahmad Hospital, Ministry of Health, Kuwait.
Ann Med Surg (Lond). 2021 Feb 2;63:102138. doi: 10.1016/j.amsu.2021.01.086. eCollection 2021 Mar.
Obesity is a complex metabolic illness that is interrelated to a plethora of complications that predispose to avoidable morbidity and mortality. The considerable impact of obesity has invited various therapies ranging from lifestyle advice, pharmacotherapy, endoscopic bariatric therapy and ultimately surgery. Intragastric balloons are space-occupying therapies that aim to increase satiety through mechanical and neuroendocrine mechanisms. Their prevalence is owed to their ease of administration and general safety. However, long term data concerning safety and efficacy is scarce when considering the various types of balloons in use. In this review, we discuss the intragastric balloon comprehensively in terms of efficacy, safety, limitations and future direction.
肥胖是一种复杂的代谢性疾病，与大量易导致可避免的发病和死亡的并发症相关。肥胖的巨大影响引发了从生活方式建议、药物治疗、内镜减重治疗到最终手术等各种治疗方法。胃内球囊是一种占据空间的治疗方法，旨在通过机械和神经内分泌机制增加饱腹感。它们的普及归因于其易于施用和总体安全性。然而，考虑到使用的各种类型的球囊，关于安全性和有效性的长期数据却很匮乏。在这篇综述中，我们从疗效、安全性、局限性和未来方向等方面全面讨论胃内球囊。
